Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Bristol-Myers Squibb Co. (NYSE: BMY) closed the day trading at $44.70 down -8.51% from the previous closing price of $48.86. In other words, the price has decreased by -$8.51 from its previous closing price. On the day, 45.03 million shares were traded. BMY stock price reached its highest trading level at $47.5 during the session, while it also had its lowest trading level at $44.37.
Ratios:
For a better understanding of BMY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.16. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 1.41 whereas as Long-Term Debt/Eq ratio is at 1.30.
On February 06, 2024, Redburn Atlantic Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $77 to $54.
BofA Securities Downgraded its Buy to Neutral on January 03, 2024, whereas the target price for the stock was revised from $68 to $60.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 05 ’23 when BOERNER CHRISTOPHER S. bought 2,000 shares for $49.78 per share. The transaction valued at 99,560 led to the insider holds 82,672 shares of the business.
BOERNER CHRISTOPHER S. bought 3,071 shares of BMY for $150,049 on Nov 28 ’23. The Chief Executive Officer now owns 79,384 shares after completing the transaction at $48.86 per share. On Nov 20 ’23, another insider, Samuels Theodore R. II, who serves as the Director of the company, bought 8,500 shares for $49.81 each. As a result, the insider paid 423,385 and bolstered with 35,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 99027484672 and an Enterprise Value of 128100368384. As of this moment, Bristol-Myers’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.59, and their Forward P/E ratio for the next fiscal year is 6.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.01 while its Price-to-Book (P/B) ratio in mrq is 3.07. Its current Enterprise Value per Revenue stands at 2.846 whereas that against EBITDA is 6.954.
Stock Price History:
Over the past 52 weeks, BMY has reached a high of $70.93, while it has fallen to a 52-week low of $47.58. The 50-Day Moving Average of the stock is -12.51%, while the 200-Day Moving Average is calculated to be -17.65%.
Shares Statistics:
Over the past 3-months, BMY traded about 15.49M shares per day on average, while over the past 10 days, BMY traded about 14749920 shares per day. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 78.17% stake in the company. Shares short for BMY as of 1713139200 were 34364180 with a Short Ratio of 2.22, compared to 1710460800 on 37254166. Therefore, it implies a Short% of Shares Outstanding of 34364180 and a Short% of Float of 1.7000000000000002.
Dividends & Splits
BMY’s forward annual dividend rate is 2.34, up from 2.31 a year ago. Against a Trailing Annual Dividend Yield of 0.047277935The stock’s 5-year Average Dividend Yield is 3.22.
